We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Response to Lyme Disease Determined by Individual's Genetic Makeup

By LabMedica International staff writers
Posted on 27 Oct 2008
Print article
Lyme disease can have dramatically different outcomes in different people. Symptoms range from debilitating disease to no symptoms at all and scientists have attributed the differences in people's response to Lyme disease to the unique genetic makeup of each individual.

In the United States and Europe, Lyme disease is caused by tick-borne bacteria called Borrelia. Testing is a challenge because symptoms vary and often mimic flu-like symptoms. The bite may not immediately result in antibody production so early negative diagnosis is not definitive. The organism is also difficult to culture and is slow growing, which complicate detection.

A team of scientists used a mice model to examine whether a person's immune response to Borrelia could determine the outcome of the disease. The team has identified and synthesized key peptides that are predicted to have high binding affinity to an individual's immune cells based on the genetic traits of his/her immune system. It has also tested the newly identified peptides in mouse models in which the immunological genes are very well characterized. Lastly, the team demonstrated that the "targeted, computationally predicted peptides" significantly reduce the number and "activation state" of the cells responding to Borrelia proteins.

"If infection is detected very early, a round of antibiotics sometimes is enough for some people. In other cases, even with antibiotics, the disease becomes chronic and includes symptoms like arthritis, heart disease, and harm to the nervous system," said Dr. M. Karen Newell, Ph.D., lead investigator of the study and a professor at the University of Colorado (Boulder, CO, USA).

Viral Genetics initially unveiled the new model and early findings on Saturday, October 18, 2008, at the International Lyme & Associated Diseases Society (ILADS) Scientific Session. The study model potentially applies to human immunodeficiency virus (HIV)/AIDS and other immune based diseases.

Related Links:
University of Colorado


New
Gold Member
Troponin T QC
Troponin T Quality Control
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Clinical Sample Concentrator
QIAamp DSP Virus Kit
New
Dengue Virus Immunochromatographic Assay
STANDARD Q Dengue IgM/IgG Test

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: The CELLSEARCH System is the first and only clinically validated, FDA-cleared system for identification, isolation, and enumeration of CTCs from a simple blood test (Photo courtesy of Menarini, Inc.)

Early Blood Test Predicts Survival in Patients with Metastatic Prostate Cancer

Before prostate cancer spreads, it can be effectively treated with surgery or radiation. However, once the cancer metastasizes and becomes incurable, systemic treatments are used to extend survival as... Read more

Hematology

view channel
Image: The discovery of a new blood group has solved a 50- year-old mystery (Photo courtesy of 123RF)

Newly Discovered Blood Group System to Help Identify and Treat Rare Patients

The AnWj blood group antigen, a surface marker discovered in 1972, has remained a mystery regarding its genetic origin—until now. The most common cause of being AnWj-negative is linked to hematological... Read more

Pathology

view channel
Image: Confocal- & laminar flow-based detection scheme of intact virus particles, one at a time (Photo courtesy of Paz Drori)

Breakthrough Virus Detection Technology Combines Confocal Fluorescence Microscopy with Microfluidic Laminar Flow

Current virus detection often relies on polymerase chain reaction (PCR), which, while highly accurate, can be slow, labor-intensive, and requires specialized lab equipment. Antigen-based tests provide... Read more

Industry

view channel
Image: The GeneXpert system’s fast PCR Xpert tests can fight AMR and superbugs with fast and accurate PCR in one hour (Photo courtesy of Cepheid)

Cepheid Partners with Fleming Initiative to Fight Antimicrobial Resistance

Antimicrobial resistance (AMR) is responsible for over one million deaths globally each year and poses a growing challenge in treating major infectious diseases like tuberculosis, Escherichia coli (E.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.